# EDGAR Filing Document

**Accession Number:** 0001856156
**File Stem:** 0001752724-23-048796
**Filing Date:** 2023-3
**Character Count:** 76737
**Document Hash:** c8a82b853c61cb77a80812df8c0d63c6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-23-048796.hdr.sgml**: 20230301

**ACCESSION NUMBER**: 0001752724-23-048796

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230301

**DATE AS OF CHANGE**: 20230301

**PERIOD START**: 20230331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MVP Private Markets Fund
- **CENTRAL INDEX KEY:** 0001856156
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-23656
- **FILM NUMBER:** 23690468

**BUSINESS ADDRESS:**
- **STREET 1:** 9 OLD KINGS HIGHWAY
- **CITY:** DARIEN
- **STATE:** CT
- **ZIP:** 06820
- **BUSINESS PHONE:** (203) 662-3456

**MAIL ADDRESS:**
- **STREET 1:** 9 OLD KINGS HIGHWAY
- **CITY:** DARIEN
- **STATE:** CT
- **ZIP:** 06820

## Nport-Ex

**MVP PRIVATE MARKETS FUND** 

**CONSOLIDATED SCHEDULE OF INVESTMENTS** 

**December 31, 2022 (UNAUDITED)** 

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Description** | **Cost** | **Fair Value** | **Percentage of<br> Net Assets** | **Acquisition<br> Date** |
| **Direct Credit (11.93%)** |  |  |  |  |
| Aero Operating, LLC (3M US L + 6.50%, 2/6/2026)<sup>(a)(b)</sup> | $6536715 | $6480341 | 1.26% | &nbsp;&nbsp;&nbsp;&nbsp;12/17/2021 |
| Beacon Oral Specialist (3M US L+ 6%, 12/14/2025)<sup>(a)(b)</sup> | 5610030 | 5460007 | 1.06% | &nbsp;&nbsp;&nbsp;&nbsp;4/4/2022 |
| CMS Mechanical (3M US SOFR + 5% 11/18/2026)<sup>(a)(b)</sup> | 1940411 | 1940411 | 0.38% | &nbsp;&nbsp;&nbsp;&nbsp;12/22/2022 |
| Erie Construction Mid-West, LLC (3M US SOFR + 4.75%, 6/30/2027)<sup>(a)(b)</sup> | 966011 | 966011 | 0.19% | &nbsp;&nbsp;&nbsp;&nbsp;8/9/2022 |
| MDME Holdings, LLC (3M SOFR + 6.00%, 8/3/2027)<sup>(a)(b)</sup> | 1930091 | 1930091 | 0.38% | &nbsp;&nbsp;&nbsp;&nbsp;8/3/2022 |
| MDME Incremental T/L (3M SOFR + 6.00%, 8/3/2027)<sup>(a)(b)</sup> | 973133 | 973133 | 0.19% | &nbsp;&nbsp;&nbsp;&nbsp;11/22/2022 |
| NAS, LLC (3M US L + 6.50%, 6/3/2024)<sup>(a)(b)</sup> | 8715581 | 8799284 | 1.72% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Netrix, LLC, (3M US L + 8.05%, 7/31/2026)<sup>(a)(b)</sup> | 1558941 | 1469226 | 0.29% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| North Acquisition LLC (3M SOFR + 6.75%, 9/30/2027)<sup>(a)(b)</sup> | 7344493 | 7344493 | 1.43% | &nbsp;&nbsp;&nbsp;&nbsp;7/27/2022 |
| Omni Intermediate Holdings DDTL Tranche 4 (3M US L + 5%, 12/30/2026)<sup>(a)(b)</sup> | 282678 | 283049 | 0.06% | &nbsp;&nbsp;&nbsp;&nbsp;6/24/2022 |
| Omni Intermediate Holdings, (3M US L + 5%, 12/30/2026)<sup>(a)(b)</sup> | 5777947 | 5777804 | 1.13% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Omni Intermediate Holdings, LLC Delayed TL (3M US L + 5%, 12/30/2026)<sup>(a)(b)</sup> | 629374 | 628997 | 0.12% | &nbsp;&nbsp;&nbsp;&nbsp;8/26/2022 |
| Omni Intermediate Holdings, LLC TL 1L (3M US L + 5%, 12/30/2026)<sup>(a)(b)</sup> | 707897 | 714769 | 0.14% | &nbsp;&nbsp;&nbsp;&nbsp;6/24/2022 |
| Oral Surgery Partners, LLC (3M US SOFR + 5.5% 5/10/2024)<sup>(a)(b)</sup> | 2941128 | 2941128 | 0.57% | &nbsp;&nbsp;&nbsp;&nbsp;10/31/2022 |
| Orthodontic Partner LLC DDTL2 (3M US SOFR + 5.25% 10/12/2027)<sup>(a)(b)</sup> | 992500 | 992500 | 0.19% | &nbsp;&nbsp;&nbsp;&nbsp;12/28/2022 |
| Orthodontic Partners, LLC DDTL (3M US SOFR + 5.25% 10/12/2027)<sup>(a)(b)</sup> | 1978985 | 1978985 | 0.39% | &nbsp;&nbsp;&nbsp;&nbsp;8/22/2022 |
| PLA Buyer, LLC (3M US L + 5.9%, 6/30/2023)<sup>(a)(b)</sup> | 7379457 | 7355372 | 1.43% | &nbsp;&nbsp;&nbsp;&nbsp;6/3/2022 |
| Spectrum Vision, (3M US L + 6.5%, 5/17/2023)<sup>(a)(b)</sup> | 5103867 | 5131831 | 1.00% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Total Direct Credit | $61369239 | $61167432 |  |  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Description** | **Cost** | **Fair Value** | **Percentage of<br> Net Assets** | **Acquisition<br> Date** |
| **Direct Equity (20.31%)** |  |  |  |  |
| BA Hissho Blocker, LLC<sup>(a)(b)</sup> | $5000000 | $5680979 | 1.11% | &nbsp;&nbsp;&nbsp;&nbsp;5/16/2022 |
| Biloxi Co-Investment , L.P.<sup>(b)</sup> | 3627385 | 3976309 | 0.78% | &nbsp;&nbsp;&nbsp;&nbsp;8/11/2021 |
| Charger Investment , L.P.<sup>(b)</sup> | 4000000 | 4637483 | 0.90% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Cop Lawn Services INV, LLC<sup>(b)</sup> | 5546000 | 5546000 | 1.08% | &nbsp;&nbsp;&nbsp;&nbsp;11/18/2022 |
| Cynosure 2020 Co-Investment, LLC Series B<sup>(b)</sup> | 924196 | 2526950 | 0.49% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Incline V RKD Co-Invest A, L.P.<sup>(b)</sup> | 12070044 | 12070044 | 2.35% | &nbsp;&nbsp;&nbsp;&nbsp;8/31/2022 |
| MDME Holdings, LLC<sup>(b)</sup> | 50000 | 50000 | 0.01% | &nbsp;&nbsp;&nbsp;&nbsp;8/31/2022 |
| MFG Mellott Fund A, LLC<sup>(b)</sup> | 3000000 | 7417959 | 1.45% | &nbsp;&nbsp;&nbsp;&nbsp;9/9/2021 |
| MiddleGround Checker Co-Invest Partners, L.P.<sup>(b)</sup> | 11641419 | 13742210 | 2.68% | &nbsp;&nbsp;&nbsp;&nbsp;2/10/2022 |
| MiddleGround Royal Palm Co-Invest Partners, L.P.<sup>(b)</sup> | 7651263 | 9994244 | 1.95% | &nbsp;&nbsp;&nbsp;&nbsp;2/10/2022 |
| North Acquisition, LLC<sup>(b)</sup> | 150000 | 150000 | 0.03% | &nbsp;&nbsp;&nbsp;&nbsp;7/27/2022 |
| OEP VIII Project Vector Co-Investment<sup>(b)</sup> | 8000000 | 14729616 | 2.87% | &nbsp;&nbsp;&nbsp;&nbsp;12/20/2021 |
| RCP Monte Nido Co-Investment Fund, L.P.<sup>(b)</sup> | 12000000 | 12000000 | 2.34% | &nbsp;&nbsp;&nbsp;&nbsp;8/31/2022 |
| Ridgemont Equity Coinvest III AGP Blocker, L.P.<sup>(a)(b)</sup> | 4545454 | 7130436 | 1.39% | &nbsp;&nbsp;&nbsp;&nbsp;10/21/2021 |
| V-Sky Co-Invest Aggregator II, L.P.<sup>(b)</sup> | 5007539 | 4496661 | 0.88% | &nbsp;&nbsp;&nbsp;&nbsp;9/2/2021 |
| Total Direct Equity | $83213300 | $104148891 |  |  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Description** | **Cost** | **Fair Value** | **Percentage of<br> Net Assets** | **Acquisition<br> Date** |
| **Secondary Investment (57.69%)** |  |  |  |  |
| ABRY IX, L.P.<sup>(b)(c)</sup> | 13140203 | 16845385 | 3.29% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Accel-KKR Capital Partners CV IV Strategic Fund, L.P.<sup>(b)(c)</sup> | 6277158 | 6171783 | 1.20% | &nbsp;&nbsp;&nbsp;&nbsp;3/22/2022 |
| Battery Ventures XII Side Fund, L.P.<sup>(b)(c)</sup> | 6483269 | 7095370 | 1.38% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Battery Ventures XII, L.P.<sup>(b)(c)</sup> | 10138902 | 13803238 | 2.69% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Berkshire Fund IX, L.P.<sup>(b)(c)</sup> | 12659819 | 14159728 | 2.76% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Charlesbank Equity Fund IX, L.P.<sup>(b)(c)</sup> | 8865400 | 10452568 | 2.04% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| CSS Intermediate Holdings<sup>(b)(c)</sup> | 1942500 | 2374793 | 0.46% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| GHO Capital Virtue, L.P.<sup>(b)(c)</sup> | 7714925 | 7650441 | 1.49% | &nbsp;&nbsp;&nbsp;&nbsp;4/21/2022 |
| Hellman & Freidman Capital VIII, L.P.<sup>(b)(c)</sup> | 14538326 | 11896514 | 2.32% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| HGGC Fund II<sup>(b)(c)</sup> | 5412451 | 9755026 | 1.90% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| HGGC Fund III<sup>(b)(c)</sup> | 7150968 | 12500282 | 2.44% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Icon III, L.P.<sup>(b)(c)</sup> | 4265063 | 3437594 | 0.67% | &nbsp;&nbsp;&nbsp;&nbsp;7/12/2021 |
| Icon IV-B, L.P.<sup>(b)(c)</sup> | 2100228 | 2241759 | 0.44% | &nbsp;&nbsp;&nbsp;&nbsp;7/12/2021 |
| Insight Venture IX, L.P.<sup>(b)(c)</sup> | 26596959 | 27899396 | 5.44% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Institutional Venture XVI, L.P.<sup>(b)(c)</sup> | 2831403 | 2338760 | 0.46% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Lightyear Fund IV, L.P.<sup>(b)(c)</sup> | 7585074 | 10500572 | 2.05% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Linden Capital IV, L.P.<sup>(b)(c)</sup> | 7949249 | 10333236 | 2.02% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| New Mountain Capital V, L.P.<sup>(b)(c)</sup> | 13460180 | 17264499 | 3.37% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| New Mountain IV<sup>(b)(c)</sup> | 5196538 | 3254553 | 0.63% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Odyssey Investment V, L.P.<sup>(b)(c)</sup> | 7550147 | 7843737 | 1.53% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Platinum Equity Capital IV, L.P.<sup>(b)(c)</sup> | 10106105 | 11702261 | 2.28% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Description (continued)** | **Cost** | **Fair Value** | **Percentage of<br> Net Assets** | **Acquisition<br> Date** |
| Quad-C IX<sup>(b)(c)</sup> | $8587662 | $9583741 | 1.87% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Silver Lake V, L.P.<sup>(b)(c)</sup> | 13770028 | 10979327 | 2.14% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Stepstone Capital IV, L.P.<sup>(b)(c)</sup> | 2167043 | 2788693 | 0.54% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Thoma Bravo Fund XII, L.P.<sup>(b)(c)</sup> | 14071617 | 9946264 | 1.94% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Thoma Bravo Fund XIII, L.P.<sup>(b)(c)</sup> | 21526205 | 21149973 | 4.12% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Waud Capital IV, L.P.<sup>(b)(c)</sup> | 11543661 | 15756313 | 3.07% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Wind Point AAV, L.P.<sup>(b)(c)</sup> | 2989524 | 3352513 | 0.65% | &nbsp;&nbsp;&nbsp;&nbsp;7/8/2021 |
| Wind Point VIII, L.P.<sup>(b)(c)</sup> | 2931419 | 10604622 | 2.07% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Wind Point Partners AAV II, L.P.<sup>(b)(c)</sup> | 2306911 | 2132383 | 0.42% | &nbsp;&nbsp;&nbsp;&nbsp;9/30/2021 |
| Total Secondary Investment | $261858937 | $295815324 |  |  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Description** | **Cost** | **Fair Value** | **Percentage of<br> Net Assets** | **Acquisition<br> Date** |
| **Primary Investment (2.54%)** |  |  |  |  |
| FFL Parallel Fund V, LP<sup>(b)</sup> | 5490465 | 6656631 | 1.30% | &nbsp;&nbsp;&nbsp;&nbsp;6/16/2022 |
| One Equity Partners VIII<sup>(b)</sup> | 6182423 | 6415500 | 1.25% | &nbsp;&nbsp;&nbsp;&nbsp;4/28/2022 |
| Total Primary Investment | $11672888 | $13072131 |  |  |
| **Total Investments (92.47%)** | $**418114364** | $**474203778** |  |  |
| **Other Assets In Excess of Liabilities (7.53%)** |  | **38582647** |  |  |
| **Net Assets (100.00%)** |  | $**512786425** |  |  |

---

**Investment Abbreviations:**

LIBOR- London Interbank Offered Rate

SOFR- Secured Overnight Financing Rate

**Libor Rates:**

3M US L - 3 Month LIBOR as of December 31, 2022 was 3.74%

3M US SOFR - 3 Month SOFR as of December 31, 2022 was 4.30%

*<sup>(a)</sup>* *Level 3 securities fair valued under procedures established by the Trustees, represent 14.43% of Net Assets. The total value of these securities is $73,978,847.*

*<sup>(b)</sup>* *Investments have no redemption provisions, are issued in private placement transactions and are restricted as to resale. For investments that were acquired through multiple transactions, the acquisition date represents the initial acquisition date of the Fund's investment in the position. Total fair value of restricted securities amounts to $474,203,778, which represents 92.47% of net assets as of December 31, 2022.*

*<sup>(c)</sup>* *Investment does not allow redemptions or withdrawals except at discretion of its general partner, manager or advisor.*

*\** *All securities are domiciled in the United States.*

*See Notes to Quarterly Schedule of Investments.*

MVP Private Markets Fund

Notes to Quarterly Schedule of Investments

December 31, 2022 (Unaudited)

1. ORGANIZATION

MVP Private Markets Fund (the "Fund") was organized as a Delaware statutory trust on April 7, 2021. The Fund is registered under the Investment Company Act of 1940, as amended (the "1940 Act"), as a non-diversified, closed-end management investment company. The Fund's investment adviser is Portfolio Advisers, LLC (the "Adviser"). The Adviser is an investment adviser registered under the Investment Advisers Act of 1940, as amended (the "Advisers Act") and was organized as a limited liability company under the laws of the State of Connecticut on June 19, 1997.The Fund commenced operations on January 3, 2022 ("Commencement of Operations"). Simultaneous with the Commencement of Operations, the Predecessor Fund, through a tax-free reorganization, transferred investments, cash and other assets totaling $416,174,869 (including $45,914,879 of unrealized appreciation) into the Fund. The investments acquired by the Fund in the reorganization were valued using fair value procedures approved by the Fund's Board of Trustees. The Predecessor Fund maintained an investment objective, strategies and investment policies, guidelines and restrictions that are, in all material respects, equivalent to those of the Fund and at the time of the conversion of the Predecessor Fund was managed by the same Adviser and portfolio managers as the Fund.

The Fund's investment objective is to generate long-term capital appreciation by investing in a diversified portfolio of private market investments, with a focus on investments in mid-sized companies in the United States. The Fund will seek to achieve its investment objective through a mix of investments (the "Fund Investments") that is predominantly comprised of private equity, and to a lesser extent private credit. Fund Investments are expected to primarily consist of the following:

● direct investments in the equity or debt of target companies and other private assets (i.e. assets that are not traded on a public securities exchange) ("Direct Investments"), typically together with third-party managers ("Sponsors");

● purchases of existing interests in private equity or private credit funds ("Portfolio Funds") and other private assets managed by Sponsors ("Secondary Investments");

● subscriptions for new interests in Portfolio Funds ("Primary Investments"); and

● short-term and liquid investments, including money market funds, short term treasuries, and/or other liquid investment vehicles.

Subject to applicable law and regulation, the Fund may gain exposure to Fund Investments indirectly through pooled vehicles or special purpose vehicles managed by the Adviser, any of its affiliates or third parties.

Under normal circumstances, the Fund intends to invest and/or make capital commitments of at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in "Private Market Assets". For purposes of this policy, Private Market Assets include Direct Investments, Portfolio Funds, Secondary Investments, and Primary Investments.

The Fund's Board of Trustees (the "Board") has overall responsibility for the management and supervision of the business operations of the Fund on behalf of the shareholders. A majority of Trustees of the Board are and will be persons who are not "interested persons," as defined in Section 2(a)(19) of the 1940 Act (the "Independent Trustees"). To the extent permitted by the 1940 Act and other applicable law, the Board may delegate any of its rights, powers and authority to, among others, the officers of the Fund, any committee of the Board, service providers or the Adviser.

The Fund offers three separate classes of shares of beneficial interest ("Shares") designated as Class A Shares, Class I Shares and Class D Shares. Each class of Shares is subject to different fees and expenses. The Fund may offer additional classes of Shares in the future. The Fund has received an exemptive order from the SEC with respect to the Fund's multi-class structure. The purchase price of the Shares at the Commencement of Operations was $10.00 per Share. Thereafter, the purchase price Shares was based on the net asset value per Share as of the date such Shares were purchased. Fractions of Shares are issued to one one-thousandth of a Share.

The minimum initial investment in the Fund for Class A Shares and Class D Shares is $50,000, and the minimum initial investment for Class I Shares is $5,000,000 except for additional purchases pursuant to the dividend reinvestment plan. However, the Fund, in its sole discretion, may accept investments below these minimums. Investors subscribing through a given broker/dealer or registered investment adviser may have shares aggregated to meet these minimums, so long as denominations are not less than $50,000 and incremental contributions are not less than $5,000.

Shares will generally be offered for purchase as of the first business day of each month, except that Shares may be offered more or less frequently as determined by the Board in its sole discretion. Investments in Class A Shares and Class D Shares of the Fund are sold subject to a sales charge of up to 3.50% of the investment. For some investors, the sales charge may be waived or reduced (in whole or in part). The full amount of sales charge may be reallowed to brokers or dealers participating in the offering.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The Fund meets the definition of an investment company and follows the accounting and reporting guidance as issued through the Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 946, *Financial Services – Investment Companies*.

The following is a summary of significant accounting policies followed by the Fund in the preparation of its financial statements. These policies are in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP").

**Short-Term Investments:** Short-term investments represent investments in high quality money market instruments and money market mutual funds, and are recorded at NAV per share which approximates fair value. Money market instruments are high quality, short-term fixed-income obligations, which generally have remaining maturities of one year or less and may include U.S. Government securities, commercial paper, certificates of deposit and bankers acceptances issued by domestic branches of U.S. banks that are members of the Federal Deposit Insurance Corporation, and repurchase agreements.

**Investment Transactions:** Investment transactions are accounted for on a trade-date basis. The Fund accounts for realized gains and losses from its Portfolio Funds based upon the pro-rata ratio of the fair value and cost of the underlying investments at the date of redemption. Dividend and interest income and expenses are recorded on the accrual basis. Distributions from Portfolio Funds will be received as underlying investments of the Portfolio Funds are liquidated. Distributions from Portfolio Funds occur at irregular intervals, and the exact timing of distributions from the Portfolio Funds has not been communicated from the Portfolio Funds. It is estimated that distributions will occur over the life of the Investment Funds.

**Fair Value of Financial Instruments:** The fair value of the Fund's assets and liabilities which qualify as financial instruments approximates the carrying amounts presented in the Consolidated Statement of Assets and Liabilities. The Fund values its investments in portfolio funds at fair value in accordance with FASB ASC 820, *Fair Value Measurement* ("ASC 820"). See Note 3 for more information.

3. PORTFOLIO VALUATION

ASC 820 defines fair value as the value that the Fund would receive to sell an investment or pay to transfer a liability in a timely transaction with an independent buyer in the principal market, or in the absence of a principal market, the most advantageous market for the investment or liability. ASC 820 establishes a three-level hierarchy for fair value measurements based upon the transparency of inputs to the valuation of an asset or liability. Inputs may be observable or unobservable and refer broadly to the assumptions that market participants would use in pricing the asset or liability. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Fund. Unobservable inputs reflect the Fund's own assumptions about the assumptions that market participants would use in valuing the asset or liability developed based on the best information available in the circumstances. Each investment is assigned a level based upon the observation of the inputs which are significant to the overall valuation.

The three-tier hierarchy of inputs is summarized below:

Level 1 — unadjusted quoted prices in active markets for identical financial instruments that the reporting entity has the ability to access at the measurement date.

---

| | |
|:---|:---|
| Level 2 — | inputs other than quoted prices included within Level 1 that are observable for the financial instrument, either directly or indirectly. Level 2 inputs also include quoted prices for similar assets and liabilities in active markets, and quoted prices for identical or similar assets and liabilities in markets that are not active. |

---

Level 3 — significant unobservable inputs for the financial instrument (including management's own assumptions in determining the fair value of investments).

Investments in Portfolio Funds are recorded at fair value, using the Investment Funds' NAV as a "practical expedient," in accordance with ASC 820.

The private equity Portfolio Funds generally are restricted securities that are subject to substantial holding periods and are not traded in public markets, so that the Fund may not be able to resell some of its investments for extended periods, which may be several years. The types of private equity Portfolio Funds that the Fund may make investments in include primary and secondary investments. Primary investments are investments in newly established private equity funds. Secondary investments are investments in existing private equity funds that are acquired in privately negotiated transactions.

The net asset value of the Fund is determined by, or at the direction of, the Adviser as of the close of business at the end of any fiscal period in accordance with the valuation principles set forth below and as may be determined, from time to time, pursuant to policies established by the Board. The Fund's investments are subject to the terms and conditions of the respective operating agreements and offering memorandums, as appropriate. ASC 820 provides for the use of net asset value (or its equivalent) as a practical expedient to estimate fair value of investments in Portfolio Funds, provided certain criteria are met. The Fund has established valuation processes and procedures to ensure that the valuation techniques are fair and consistent, and valuation inputs are supportable. The Valuation Committee (the "Committee") oversees the implementation of those valuation process of the Fund's investments. The Fund's investments in Portfolio Funds are carried at fair value which generally represents the Fund's pro-rata interest in the net assets of each Portfolio Fund as reported by the administrators and/or investment managers of the underlying Portfolio Funds. All valuations utilize financial information supplied by each Portfolio Fund and are net of management and incentive fees or allocations payable to the Portfolio Funds' managers or pursuant to the Portfolio Funds' agreements. The Portfolio Funds value their underlying investments in accordance with policies established by each Portfolio Fund, as described in each of their financial statements or offering memoranda. The Fund's valuation procedures require the Adviser to consider all relevant information available at the time the Fund values its portfolio. The Adviser has assessed factors including, but not limited to, the individual Portfolio Funds' compliance with fair value measurements, price transparency and valuation procedures in place. The Adviser and/or the Board will consider such information and consider whether it is appropriate, in light of all relevant circumstances, to value such a position at its net asset value as reported or whether to adjust such value. The underlying investments of each Portfolio Fund are accounted for at fair value as described in each Portfolio Fund's financial statements.

The Adviser employs ongoing due diligence policies and processes with respect to Portfolio Funds and their investment managers. The Adviser assesses the quality of information provided and determines whether such information continues to be reliable or whether additional inquiry is necessary. Such inquiries may require the Adviser to forego its normal reliance on the value provided and to independently determine the fair value of the Fund's interest in such Investment Fund.

The fair value relating to certain underlying investments of these Portfolio Funds, for which there is no ready market, has been estimated by the respective Portfolio Funds' management and is based upon available information in the absence of readily ascertainable fair values and does not necessarily represent amounts that might ultimately be realized. Due to the inherent uncertainty of valuation, those estimated fair values may differ significantly from the values that would have been used had a ready market for the investments existed. These differences could be material.

The Fund may also make Direct Investments, which may include debt and/or equity securities issued by operating companies and are typically made as investments alongside a private equity fund.

The Adviser determines comparable public companies based on industry, size, developmental stage, strategy, etc., and then calculates a trading multiple for each comparable company identified by dividing the enterprise value of the comparable company by its earnings before interest, taxes, depreciation and amortization (EBITDA). The trading multiple may then be discounted for considerations such as differences between the comparable companies and the subject company based on company specific facts and circumstances. The combined multiple is then applied to the subject company to calculate the value of the subject company.

The Adviser applies comparable precedent transaction multiples where such multiples are available and appropriate. Where such comparable multiples are not available or are inappropriate generally, a comparable trading multiples or a discounted cash flow analysis is performed to estimate fair value. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement falls in its entirety, is determined based on the lowest level input that is significant to the fair value measurement in its entirety. The inputs or methodologies used for valuing investments are not necessarily an indication of the risk associated with investing in those securities. Changes in valuation techniques may result in transfers in or out of an investment's assigned level as described above. The Fund recognize transfers at the beginning of the year. There were no transfers in or out of Level 3 fair value measurements during the fiscal period.

Debt investments are fair valued by the Adviser using the following methods, in order of priority:

● *Market Price* - The Adviser uses the average of the liquid market bid/offer prices for the Fund's debt investments from a reliable industry source, when available.

● *Relative value analysis based on a comparable instrument* - In the absence of such liquid market bid/offer prices, the Adviser utilizes a relative value analysis based on a comparable instrument when available to value the mezzanine debt investments of the Partnerships.

● *Relative value analysis based on corporate credit curve* - The Adviser values the mezzanine debt investments based on a corporate credit curve, typically BBB-rated due to its large range of issuer data points, and obtains the curve data from Bloomberg or a reputable broker dealer. The spread between the yield on the invested instrument at the time of investment and the selected credit curve yield for the relevant maturity is measured and applied to the prevailing corresponding value on the selected credit curve over time to calculate a fair value yield and price for the investment.

● *Waterfall approach* - The Adviser estimates the enterprise value of the issuer as a multiple of earnings. If the enterprise value exceeds the accreted face value of the invested Instrument plus the accreted face value of any other indebtedness of the issuer that is senior or pari passu in ranking to the invested instrument, less unrestricted cash of the issuer, the investment is valued at par. This approach is rarely employed by <br> the Adviser.

● *Recovery estimate* - In the case of issuers going through insolvency or other restructuring processes, a subjective estimate of recovery value will be used to value the invested instrument. Recovery estimates are often provided by a third-party restructuring advisor, and the Adviser takes a conservative approach with respect to incorporating these recovery estimates in to the Fund's valuation estimates.

The following table represents the inputs used to value the investments at fair value on the Consolidated Statement of Assets and Liabilities within the valuation hierarchy as of December 31, 2022:

Primary and secondary Investments fair valued using net asset value (or its equivalent) as a practical expedient are not included in the fair value hierarchy. As such, investments in securities with a fair value of $400,224,839 are excluded from the fair value hierarchy as of December 31, 2022.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Investments in Securities at Value\*** | **Level 1 - Quoted Prices** | **Level 2 - Significant Observable Inputs** | **Level 3 - Significant Unobservable Inputs** | **Total** |
| Direct Credit | $– | $– | $61167432 | $61167432 |
| Direct Equity |  |  | 12811415 | 104148891 |
| Primary Investment |  |  |  | 13072131 |
| Secondary Investment | – | – | – | 295815324 |
| Total | $– | $– | $73978847 | $474203778 |

---

The following is a reconciliation of investments in which significant unobservable inputs (Level 3) were used in determining fair value:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Direct Credit** | **Direct Equity** | **Secondary Investments** | **Total** |
| Balance as of March 31, 2021 | $25055833 | $45374053 | $6277158 | $76707044 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued discount/ premium | 137443 |  |  | 137443 |
| &nbsp;&nbsp;&nbsp;&nbsp;Realized Gain/(Loss) | 2911 |  |  | 2911 |
| &nbsp;&nbsp;&nbsp;Change in Unrealized Appreciation/(Depreciation) | (34565) | 19980633 | (105375) | 19840693 |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases | 2703207 | 9297376 |  | 12000583 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales Proceeds | (206343) | (319216) |  | (525559) |
| &nbsp;&nbsp;&nbsp;&nbsp;Transfer into Level 3 | 33508946 |  |  | 33508946 |
| &nbsp;&nbsp;&nbsp;&nbsp;Transfer out of Level 3 | – | (61521431) | (6171783) | (67693214) |
| Balance as of December 31, 2022 | $61167432 | $12811415 | $– | $73978847 |

---

The net change in unrealized appreciation/(depreciation) included in the Consolidated Statement of Operations attributable to Level 3 assets still held as of December 31, 2022 is $3,231,395.

The following table presents additional quantitative information about valuation methodologies and inputs used for investments that are measured at fair value and categorized within Level 3 as of December 31, 2022:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Asset Class** | **Fair Value at December 31, 2022** | **Valuation <br> Techniques** | **Unobservable Input** | **Range of Input** | **Weighted Average <br> of Input** | | **Impact to<br> Valuation from an Increase <br> in Input** |
| Direct Credit | $42100680 | Relative Value Analysis | Yield to Maturity | 12.9% | 12.9 | % | Decrease |
| Direct Credit | 19066752 | Recent transaction | N/A | N/A | N/A |  | N/A |
| Direct Equity | 12811415 | Market Comparable Companies | EBITDA Multiple | 14.9x - 17.3x | 16.2 | x | Increase |

---

The Fund's investments in Portfolio funds, along with their corresponding unfunded commitments and other attributes, as of December 31, 2022, are briefly summarized in the table below.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Financing Stage** | **Investment Strategy** | **Fair Value** | **Unfunded Commitments** | **Remaining Life** | **Redemption Frequency** | **Notice Period (In Days)** | **Redemption Restriction Terms** |
| Buyout | Control investments in established companies | $411364752 | $67222472 | Up to 10 Years |  | N/A | N/A |
| Growth Capital | Non-control investments in established companies with strong growth characteristics | 51136764 | 1015701 | Up to 10 Years |  | N/A | N/A |
| Special Situations/ Other | Investments in mezzanine, distressed debt, energy/utility <br> and turnarounds | 11702261 | 1083019 | Up to 10 Years |  | N/A | N/A |

---

*\** *The information summarized in the table above represents the general terms for the specified financing stage. Individual Portfolio Funds may have terms that are more or less restrictive than those terms indicated for the asset class as a whole. In addition, most Portfolio Funds have the flexibility, as provided for in their constituent documents, to modify and waive such terms.*

Private equity is a common term for investments that typically are made in non-public companies through privately negotiated transactions. Private equity investors generally seek to acquire quality assets at attractive valuations and use operational expertise to enhance value and improve portfolio company performance. Buyout funds acquire private and public companies, as well as divisions of larger companies. Private equity specialists then seek to uncover value-enhancing opportunities in portfolio companies, unlock the value of the portfolio company and reposition it for sale at a multiple of invested equity.

The following outlines the primary investment strategies of the Portfolio Funds held by the Fund as of December 31, 2022.

**Buyouts:** Control investments in established, cash flow positive companies are usually classified as buyouts. Buyout investments may focus on small-, mid- or large-capitalization companies, and such investments collectively represent a substantial majority of the capital deployed in the overall private equity market. The use of debt financing, or leverage, is prevalent in buyout transactions—particularly in the large-cap segment.

**Venture Capital:** Investments in new and emerging companies are usually classified as venture capital. Such investments are often in technology, healthcare or other high growth industries. Companies financed by venture capital are generally not cash flow positive at the time of investment and may require several rounds of financing before the company can be sold privately or taken public. Venture capital investors may finance companies along the full path of development or focus on certain sub-stages (usually classified as seed, early and late stages) in partnership with other investors.

**Special Situations:** A broad range including mezzanine, distressed debt, energy/utility investments and turnarounds.

Types of private equity investments that the Fund may make include:

*Primary Investments.* Primary investments (primaries) are interests or investments in newly established private equity funds. Primary investors subscribe for interests during an initial fundraising period, and their capital commitments are then used to fund investments in a number of individual operating companies during a defined investment period.

*Secondary Investments.* Secondary investments (secondaries) are interests in existing private equity funds that are acquired in privately negotiated transactions, typically after the end of the private equity fund's fundraising period.

*Direct Investments.* Direct investments involve taking an interest in securities issued by an operating company, whether equity or credit. Direct equity investments generally involve new owners taking a material stake in the target company, frequently a controlling interest, and exercising significant influence on the growth and development of the company through work with the company's management and board of directors. Direct credit investments often represent financing for buyout or growth investments and may have various features and covenants designed to protect the lender's interests; such investments may include both secured and unsecured loans, bonds and/or other forms of debt. Direct investments may vary in duration, but usually are exited within two to six years.

4. INDEMNIFICATION

The Fund indemnifies its officers and managers for certain liabilities that may arise from the performance of their duties to the Fund. Additionally, in the normal course of business, the Fund enters into contracts that contain a variety of representations and warranties which provide general indemnities. The Fund's maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Fund that have not yet occurred. However, the Fund expects the risk of loss due to these warranties and indemnities to be remote.

5. PRINCIPAL RISK FACTORS

**Closed-End Fund; Liquidity Limited to Periodic Repurchases of Shares.** The Fund is a non-diversified, closed-end management investment company designed primarily for long-term investors. The Fund is neither a liquid investment nor a trading vehicle. An investor should not invest in the Fund if the investor needs a liquid investment. Closed-end funds differ from open-end management investment companies (commonly known as mutual funds) in that investors in a closed-end fund do not have the right to redeem their shares on a daily basis.

The Fund does not currently intend to list the Shares for trading on any securities exchange, and the Fund does not expect any secondary market to develop for the Shares. Although the Board may, in its sole discretion, cause the Fund to offer to repurchase outstanding Shares at their net asset value (after all applicable fees), or, in certain circumstances, at a discount, and the Adviser intends to recommend to the Board that, in normal market circumstances, the Fund conduct repurchase offers of no more than 5% of the Fund's net assets generally quarterly beginning on date approximately 10 months from launch (or such earlier or later date as the Board may determine) and thereafter quarterly on or about each December 31, March 31, June 30 and September 30, Shares are considerably less liquid than shares of funds that trade on a stock exchange, or Shares of open-end registered investment companies. It is possible that the Fund may be unable to repurchase all of the Shares that an investor tenders due to the illiquidity of the Fund Investments or if the shareholders request the Fund to repurchase more Shares than the Fund is then offering to repurchase. There can be no assurance that the Fund will conduct repurchase offers in any particular period and shareholders may be unable to tender Shares for repurchase for an indefinite period of time.

There will be a substantial period of time between the date as of which shareholders must submit a request to have their Shares repurchased and the date they can expect to receive payment for their Shares from the Fund. Shareholders whose Shares are accepted for repurchase bear the risk that the Fund's net asset value may fluctuate significantly between the time that they submit their repurchase requests and the date as of which such Shares are valued for purposes of such repurchase. Shareholders will have to decide whether to request that the Fund repurchase their Shares without the benefit of having current information regarding the value of Shares on a date proximate to the date on which Shares are valued by the Fund for purposes of effecting such repurchases.

**Pandemic Risk.** An outbreak of respiratory disease caused by a novel coronavirus was first detected in China in December 2019 and has spread internationally, and since then, the number of cases has fluctuated and new "variants" have been confirmed around the world. The outbreak has resulted in closing borders and quarantines, enhanced health screenings, cancellations, disrupted supply chains and customer activity, and has produced general concern and uncertainty. The impact of this coronavirus, and other epidemics and pandemics that may arise in the future, could affect national and global economies, individual companies and the market in general in a manner that cannot be foreseen at the present time. Health crises caused by the outbreak may heighten other pre-existing political, social and economic risks in a country or region. In the event of a pandemic or an outbreak, there can be no assurance that the Fund and its service providers will be able to maintain normal business operations for an extended period of time or will not lose the services of key personnel on a temporary or long-term basis due to illness or other reasons. Although vaccines are becoming more widely available, the duration of the COVID-19 outbreak and its full impacts are unknown and the pace of recovery may vary from market to market, resulting in a high degree of uncertainty for potentially extended periods of time, especially in certain sectors in which the Fund may make investments.

**Non-Diversified Status.** The Fund is a "non-diversified" management investment company. Thus, there are no percentage limitations imposed by the 1940 Act on the Fund's assets that may be invested, directly or indirectly, in the securities of any one issuer. Consequently, if one or more Fund Investments are allocated a relatively large percentage of the Fund's assets, losses suffered by such Fund Investments could result in a higher reduction in the Fund's capital than if such capital had been more proportionately allocated among a larger number of investments. The Fund may also be more susceptible to any single economic or regulatory occurrence than a diversified investment company. However, the Fund will be subject to diversification requirements applicable to RICs under the Code.

**Identification of Investments.** Identification of attractive investment opportunities by the Adviser involves a high degree of uncertainty. The success of the Fund depends on the availability of appropriate investment opportunities and the ability of the Adviser to identify, select, gain access to and consummate appropriate investments. The availability of investment opportunities for the Fund generally will be subject to market conditions and the ability of the Adviser to locate investments that are available for purchase at attractive prices. There can be no assurance that suitable investments will be available, that the Fund will be able to choose, make and realize investments in any particular company, Portfolio Fund or other investment, or that the Fund will be able to fully invest its capital. The Fund may be unable to invest on acceptable terms within the time period that the Fund anticipates or at all. To the extent that any portion of the Fund's capital is not invested, or is subject to delay before being invested, the potential return of the Fund will be diminished.

**Derivative Instruments.** Some or all of the Sponsors (subject to applicable law) and the Fund may use options, swaps, futures contracts, forward agreements and other derivatives contracts. Transactions in derivative instruments present risks arising from the use of leverage (which increases the magnitude of losses), volatility, the possibility of default by a counterparty, and illiquidity. Use of derivative instruments for hedging or speculative purposes by the Fund or the Sponsors could present significant risks, including the risk of losses in excess of the amounts invested.

**Nature of Portfolio Companies.** The Fund Investments will include direct and indirect investments in various companies, ventures and businesses ("Portfolio Companies"). This may include Portfolio Companies in the early phases of development, which can be highly risky due to the lack of a significant operating history, fully developed product lines, experienced management, or a proven market for their products. The Fund Investments may also include Portfolio Companies that are in a state of distress or which have a poor record, and which are undergoing restructuring or changes in management, and there can be no assurances that such restructuring or changes will be successful. The management of such Portfolio Companies may depend on one or two key individuals, and the loss of the services of any of such individuals may adversely affect the performance of such Portfolio Companies.

**General Risks of Secondary Investments.** The overall performance of the Fund's Secondary Investments will depend in large part on the acquisition price paid, which may be negotiated based on incomplete or imperfect information. Certain Secondary Investments may be purchased as a portfolio, and in such cases the Fund may not be able to exclude from such purchases those investments that the Adviser considers (for commercial, tax, legal or other reasons) less attractive. Similarly, certain Secondary Investments may require the Fund to make a concurrent primary commitment to a new Portfolio Fund, which commitment the Adviser may consider to be less attractive than the other assets to be acquired. Where the Fund acquires a Portfolio Fund interest as a secondary investment, the Fund will generally not have the ability to modify or amend such Portfolio Fund's constituent documents (e.g., limited partnership agreements) or otherwise negotiate the economic terms of the interests being acquired. In addition, the costs and resources required to investigate the commercial, tax and legal issues relating to Secondary Investments may be greater than those relating to Primary Investments.

**Contingent Liabilities Associated with Secondary Investments.** Where the Fund acquires a Portfolio Fund interest as a secondary investment, the Fund may acquire contingent liabilities of the seller of such interest. More specifically, where the seller has received distributions from the relevant private equity fund and, subsequently, that private equity fund recalls one or more of these distributions, the Fund (as the purchaser of the interest to which such distributions are attributable and not the seller) may be obligated to return monies equivalent to such distributions to such private equity fund. While the Fund may, in turn, make a claim against the seller for any such monies so paid to the private equity fund, there can be no assurances that the Fund would prevail on such claim.

**Non-U.S. Investments.** The Fund and the Portfolio Funds may invest in securities of companies and other issuers located outside of the United States. Investing outside of the United States involves certain considerations not usually associated with investing in securities of U.S. companies, including political and economic considerations, such as greater risks of expropriation, nationalization, confiscatory taxation, imposition of withholding or other taxes on interest, dividends, capital gains, other income or gross sale or disposition proceeds, limitations on the removal of assets and general social, political and economic instability; the relatively small size of the securities markets in certain countries; differing laws and regulations applicable to the securities and financial services industries of certain countries; fluctuations in the rate of exchange between currencies and costs associated with currency conversion; government policies that may restrict the Fund's investment opportunities; and accounting and financial reporting standards that may not be as high as comparable U.S. standards. The Fund and the Portfolio Funds may be unable to structure any such non-U.S. transactions to achieve the intended results or to sufficiently mitigate risks associated with such markets.

**Concentration of Investments.** There are no limitations imposed by the Adviser as to the amount of Fund assets that may be invested in (i) any one Fund Investment, (ii) in Portfolio Funds or other investments managed by a particular Sponsor or its affiliates, (iii) indirectly in any single industry or (iv) in any issuer. In addition, a Portfolio Fund's investment portfolio may consist of a limited number of companies and may be concentrated in a particular industry area or group. Accordingly, the Fund's investment portfolio may at times be significantly concentrated, both as to managers, industries and/or individual companies. Such concentration could offer a greater potential for capital appreciation as well as increased risk of loss. Such concentration may also be expected to increase the volatility of the Fund's investment portfolio. The Fund is, however, subject to the asset diversification requirements applicable to RICs.

**Currency Risk.** The Fund's portfolio may include direct and indirect investments in a number of different currencies. Any returns on, and the value of such investments may, therefore, be materially affected by exchange rate fluctuations, local exchange control, limited liquidity of the relevant foreign exchange markets, the convertibility of the currencies in question and/or other factors. A decline in the value of the currencies in which the Fund Investments are denominated against the U.S. Dollar may result in a decrease the Fund's net asset value. The Adviser may or may not elect to hedge the value of investments made by the Fund against currency fluctuations, and even if the Adviser deems hedging appropriate, it may not be possible, practicable or cost-effective to hedge currency risk exposure. Accordingly, the performance of the Fund could be adversely affected by such currency fluctuations.

**Valuation of the Fund's Interests in Portfolio Funds.** The valuation of the Fund's investments in Portfolio Funds is ordinarily determined based upon valuations provided by Sponsors of such Portfolio Funds which valuations are generally not audited. A majority of the securities in which the Portfolio Funds invest will not have a readily ascertainable market price and will be valued by the Sponsors. In this regard, a Sponsor may face a conflict of interest in valuing the securities, as their value may affect the Sponsor's compensation or its ability to raise additional funds. No assurances can be given regarding the valuation methodology or the sufficiency of systems utilized by any Portfolio Fund, the accuracy of the valuations provided by the Portfolio Funds, that the Portfolio Funds will comply with their own internal policies or procedures for keeping records or making valuations, or that the Portfolio Funds' policies and procedures and systems will not change without notice to the Fund. As a result, valuations of the securities may be subjective and could prove in hindsight to have been wrong, potentially by significant amounts. Subject to its oversight, the Board has delegated responsibility for the valuation of Fund Investments to the Adviser. The valuation of the Fund's investments will be performed in accordance with Financial Accounting Standards Board's Accounting Standards Codification 820 — Fair Value Measurements and Disclosures; but the Adviser may face conflicts of interest in overseeing the valuation of the Fund Investments, as the value of the Fund Investments will affect the Adviser's compensation. Moreover, the Adviser will generally not have sufficient information in order to be able to confirm or review the accuracy of valuations provided by Sponsors.

A Sponsor's information could be inaccurate due to fraudulent activity, misvaluation or inadvertent error. In any case, the Fund may not uncover errors for a significant period of time. Even if the Adviser elects to cause the Fund to sell its interests in such a Portfolio Fund, the Fund may be unable to sell such interests quickly, if at all, and could therefore be obligated to continue to hold such interests for an extended period of time. In such a case, the Sponsor's valuations of such interests could remain subject to such fraud or error, and the Adviser may, in its discretion, determine to discount the value of the interests or value them at zero.

Shareholders should be aware that situations involving uncertainties as to the valuations by Sponsors could have a material adverse effect on the Fund if a Sponsor's, the Adviser's or the Fund's judgments regarding valuations should prove incorrect. Prospective investors who are unwilling to assume such risks should not invest in the Fund.

**Discontinuation of LIBOR**

The United Kingdom's Financial Conduct Authority, which regulates London Interbank Offered Rate ("LIBOR"), has announced plans to phase out the use of LIBOR by the end of 2021, and a majority of U.S. dollar LIBOR settings will cease publication after June 30, 2023. It is possible that a subset of LIBOR settings will be published after these dates on a "synthetic" basis, but any such publications would be considered non-representative of the underlying market. The U.S. Federal Reserve, based on the recommendations of the New York Federal Reserve's Alternative Reference Rate Committee (comprised of major derivative market participants and their regulators), has begun publishing Secured Overnight Financing Rate Data that is intended to replace U.S. dollar LIBOR. Proposals for alternative reference rates for other currencies have also been announced or have already begun publication. Markets are slowly developing in response to these new reference rates. There remains uncertainty regarding the future use of LIBOR and the nature of any replacement rate. The transition process away from LIBOR may involve, among other things, increased volatility or illiquidity in markets for instruments that currently rely on LIBOR. The transition process may also result in a reduction in the value of certain instruments held by the Fund or reduce the effectiveness of related Fund transactions such as hedges. Volatility, the potential reduction in value, and/or the hedge effectiveness of financial instruments may be heightened for financial instruments that do not include fallback provisions that address the cessation of LIBOR. Any potential effects of the transition away from LIBOR on any of the financial instruments in which the Fund invests, as well as other unforeseen effects, could result in losses to the Fund.

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** MVP Private Markets Fund

- **b. Investment Company Act file number:** 811-23656

- **c. CIK number of Registrant:** 0001856156

- **d. LEI of Registrant:** 9845006EA4ADD61C2H27

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 9 OLD KINGS HIGHWAY

  - **City:** DARIEN

  - **State:** CT

  - **Foreign country:** US

  - **Zip / Postal Code:** 06820

  - **Telephone number:** 2036623456

**Item A.2. Information about the Series.**

- **a. Name of Series:** MVP Private Markets Fund

- **c. LEI of Series:** 9845006EA4ADD61C2H27

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2023-03-31

- **b. Date as of which information is reported:** 2022-12-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $542807252.31

**Total Liabilities:** $30020827.49

**Net Assets:** $512786424.82

**Delayed Delivery Securities:** $69321190.41

**Cash Not Reported:** $73747002.11

**Monthly Return Information**

| Class        | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID N/A | -0.92%               | -0.37%               | -5.61%               |
| Class ID N/A | -0.91%               | -0.37%               | -5.48%               |
| Class ID N/A | -0.92%               | -0.28%               | -5.48%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $5275537.09              | $22311488.79                               |
| Month 2  | $1353927.94              | $-25957335.80                              |
| Month 3  | $679303.24               | $-401067.94                                |

### Schedule of Portfolio Investments

| Name   | Title                                                    | Identifiers                  | Payoff Profile   | Asset Category   | Issuer Category   | Country   | Balance   | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   | Fair Value Level   | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| N/A    | Platinum Equity Capital Partners IV, L.P.                | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $11702261.00  | 2.28%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | Beacon Oral Specialist (3M US L+ 6%, 12/14/2025)         | CUSIP: N/A<br>LEI: N/A       | Long             | LON              | CORP              | US        | 5686650   | PA      | $5460007.58   | 1.06%             | 2049-12-31      | Floating      | 10.78%                | No            | 3                  | On Loan: No      |
| N/A    | Oral Surgery Partners, LLC                               | CUSIP: N/A<br>LEI: N/A       | Long             | LON              | CORP              | US        | 3000000   | PA      | $2941127.97   | 0.57%             | 2024-05-10      | Floating      | 10.81%                | No            | 3                  | On Loan: No      |
| N/A    | Sky Co-Investment Aggregator II, L.P.                    | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $4496661.00   | 0.88%             |  |  |  | No            | 3                  | On Loan: No      |
| N/A    | MDME Holdings, LLC                                       | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $50000.00     | 0.01%             |  |  |  | No            | 3                  | On Loan: No      |
| N/A    | Silver Lake Partners V, L.P.                             | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $10979326.89  | 2.14%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | Omni Intermediate Holdings, LLC TL 1L                    | CUSIP: 68217UAP4<br>LEI: N/A | Long             | LON              | CORP              | US        | 721042    | PA      | $714769.05    | 0.14%             | 2026-12-30      | Floating      | 9.31%                 | No            | 3                  | On Loan: No      |
| N/A    | FFL Parallel Fund V, LP                                  | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $6656631.00   | 1.30%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | AUDAX PRIVATE EQUITY ORIGINS FUND I, L.P                 | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $-242510.00   | -0.05%            |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | Orthodontic Partner LLC DDTL4                            | CUSIP: N/A<br>LEI: N/A       | Long             | LON              | CORP              | US        | 1000000   | PA      | $992500.00    | 0.19%             | 2027-10-12      | Floating      | 9.81%                 | No            | 3                  | On Loan: No      |
| N/A    | Waud Capital Partners QP IV, L.P.                        | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $15756312.80  | 3.07%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | NAS, LLC (3M US L + 6.50%, 6/3/2024)                     | CUSIP: N/A<br>LEI: N/A       | Long             | LON              | CORP              | US        | 8799284   | PA      | $8799283.72   | 1.72%             | 2049-12-31      | Floating      | 11.28%                | No            | 3                  | On Loan: No      |
| N/A    | Icon Partners IV B, L.P                                  | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $2241759.00   | 0.44%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | Thoma Bravo Fund XII, L.P.                               | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $9946264.23   | 1.94%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | GHO Capital Virtue, L.P.                                 | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $7650441.00   | 1.49%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | Insight Venture Partners IX, L.P.                        | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $27899395.41  | 5.44%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | Aero Operating, LLC (3M US L + 6.50%, 2/6/2026)          | CUSIP: N/A<br>LEI: N/A       | Long             | LON              | CORP              | US        | 6668389   | PA      | $6480340.80   | 1.26%             | 2049-12-31      | Floating      | 11.28%                | No            | 3                  | On Loan: No      |
| N/A    | ABRY Partners IX, L.P.                                   | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $16845385.27  | 3.29%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | Incline V RKD Co-Invest A, L.P.                          | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $12070044.13  | 2.35%             |  |  |  | No            | 3                  | On Loan: No      |
| N/A    | HGGC Fund II, L.P.                                       | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $9755026.00   | 1.90%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | North Acquisition LLC                                    | CUSIP: N/A<br>LEI: N/A       | Long             | LON              | CORP              | US        | 7481250   | PA      | $7344492.91   | 1.43%             | 2027-07-27      | Floating      | 11.06%                | No            | 3                  | On Loan: No      |
| N/A    | Berkshire Fund IX, L.P.                                  | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $14159727.89  | 2.76%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | Lightyear Fund IV, L.P.                                  | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $10500572.00  | 2.05%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | Icon Partners III, L.P.                                  | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $3437594.00   | 0.67%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | Thoma Bravo Fund XIII, L.P.                              | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $21149972.91  | 4.12%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | MDME Incremental T/L                                     | CUSIP: N/A<br>LEI: N/A       | Long             | LON              | CORP              | US        | 997500    | PA      | $973132.64    | 0.19%             | 2027-08-03      | Floating      | 10.31%                | No            | 3                  | On Loan: No      |
| N/A    | Battery Ventures XII Side Fund, L.P.                     | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $7095370.12   | 1.38%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | COP LAWN SERVICES INV LLC                                | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $5546000.00   | 1.08%             |  |  |  | No            | 3                  | On Loan: No      |
| N/A    | Odyssey Investment Partners V, L.P.                      | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $7843737.03   | 1.53%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | HGGC Fund III, L.P.                                      | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $12500282.18  | 2.44%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | Quad-C Partners IX, L.P.                                 | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $9583741.00   | 1.87%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | Fidelity Treasury Fund                                   | CUSIP: N/A<br>LEI: N/A       | Long             | STIV             | RF                | US        | 1         | NS      | $0.55         | 0.00%             |  |  |  | No            | 1                  | On Loan: No      |
| N/A    | Wind Point Partners AAV, L.P.                            | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $3352513.00   | 0.65%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | Omni Intermediate Holdings, (3M US L + 5%, 12/30/2026)   | CUSIP: N/A<br>LEI: N/A       | Long             | LON              | CORP              | US        | 5828512   | PA      | $5777803.61   | 1.13%             | 2049-12-31      | Floating      | 9.78%                 | No            | 3                  | On Loan: No      |
| N/A    | Battery Ventures XII, L.P.                               | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $13803238.14  | 2.69%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | Netrix, LLC, (3M US L + 8.05%, 7/31/2026)                | CUSIP: N/A<br>LEI: N/A       | Long             | LON              | CORP              | US        | 1584412   | PA      | $1469225.59   | 0.29%             | 2049-12-31      | Floating      | 12.83%                | No            | 3                  | On Loan: No      |
| N/A    | Erie Construction Mid-West, LLC                          | CUSIP: N/A<br>LEI: N/A       | Long             | LON              | CORP              | US        | 974992    | PA      | $966011.36    | 0.19%             | 2027-07-30      | Floating      | 9.06%                 | No            | 3                  | On Loan: No      |
| N/A    | Spectrum Vision, (3M US L + 6.5%, 5/17/2023)             | CUSIP: N/A<br>LEI: N/A       | Long             | LON              | CORP              | US        | 5153855   | PA      | $5131830.61   | 1.00%             | 2049-12-31      | Floating      | 11.28%                | No            | 3                  | On Loan: No      |
| N/A    | BA Hissho Blocker, LLC                                   | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $5680979.00   | 1.11%             |  |  |  | No            | 3                  | On Loan: No      |
| N/A    | Cynosure Partners 2020 Co-Investment, LLC                | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $2526950.00   | 0.49%             |  |  |  | No            | 3                  | On Loan: No      |
| N/A    | RCP Monte Nido Co-Investment Fund, L.P.                  | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $12000000.00  | 2.34%             |  |  |  | No            | 3                  | On Loan: No      |
| N/A    | PLA Buyer, LLC (3M US L + 5.9%, 6/30/2023)               | CUSIP: N/A<br>LEI: N/A       | Long             | LON              | CORP              | US        | 7423670   | PA      | $7355372.47   | 1.43%             | 2023-06-30      | Floating      | 10.68%                | No            | 3                  | On Loan: No      |
| N/A    | Institutional Venture Partners XVI, L.P.                 | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $2338760.33   | 0.46%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | MiddleGround Royal Palm Co-Invest Partners, L.P.         | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $9994244.00   | 1.95%             |  |  |  | No            | 3                  | On Loan: No      |
| N/A    | Silver Oak CCS SPV, L.P.                                 | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $2374793.00   | 0.46%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | OMNI INTERMEDIATE DDTL Tranche 4                         | CUSIP: N/A<br>LEI: N/A       | Long             | LON              | CORP              | US        | 285533    | PA      | $283048.84    | 0.06%             | 2026-12-30      | Floating      | 9.31%                 | No            | 3                  | On Loan: No      |
| N/A    | Biloxi Co-Investment Partners, L.P.                      | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $3976308.90   | 0.78%             |  |  |  | No            | 3                  | On Loan: No      |
| N/A    | Ares Holdings LLC                                        | CUSIP: N/A<br>LEI: N/A       | Long             | LON              | CORP              | US        | 2000000   | PA      | $1940410.97   | 0.38%             | 2026-11-18      | Floating      | 9.81%                 | No            | 3                  | On Loan: No      |
| N/A    | Ridgemont Equity Partners Coinvest III AGP Blocker, L.P. | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $7130435.50   | 1.39%             |  |  |  | No            | 3                  | On Loan: No      |
| N/A    | Wind Point Partners AAV II, L.P.                         | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $2132383.00   | 0.42%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | OEP VIII Project Vector Co-Investment Partners, L.P.     | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $14729616.00  | 2.87%             |  |  |  | No            | 3                  | On Loan: No      |
| N/A    | One Equity Partners VIII-A, L.P.                         | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $6415500.33   | 1.25%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | North Acquisition, LLC                                   | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $150000.00    | 0.03%             |  |  |  | No            | 3                  | On Loan: No      |
| N/A    | MFG Partners Mellott Fund A, LLC                         | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $7417959.38   | 1.45%             |  |  |  | No            | 3                  | On Loan: No      |
| N/A    | Omni Intermediate Holdings, LLC Delayed TL               | CUSIP: 68217UAM1<br>LEI: N/A | Long             | LON              | CORP              | US        | 634518    | PA      | $628997.43    | 0.12%             | 2027-12-29      | Floating      | 8.00%                 | No            | 3                  | On Loan: No      |
| N/A    | MiddleGround Checker Co-Invest Partners, L.P.            | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $13742210.00  | 2.68%             |  |  |  | No            | 3                  | On Loan: No      |
| N/A    | MDME Holdings, LLC                                       | CUSIP: N/A<br>LEI: N/A       | Long             | LON              | CORP              | US        | 1961625   | PA      | $1930091.09   | 0.38%             | 2027-08-03      | Floating      | 10.31%                | No            | 3                  | On Loan: No      |
| N/A    | Linden Capital Partners IV, L.P.                         | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $10333235.97  | 2.02%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | Accel-KKR Capital Partners CV IV Strategic Fund, L.P.    | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $6171783.00   | 1.20%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | Stepstone Capital Partners IV, L.P.                      | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $2788693.17   | 0.54%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | New Mountain Partners V, L.P.                            | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $17264499.18  | 3.37%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | New Mountain Partners IV, L.P                            | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $3254552.66   | 0.63%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | Charlesbank Equity Fund IX, L.P.                         | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $10452568.00  | 2.04%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | Orthodontic Partners, LLC DDTL                           | CUSIP: N/A<br>LEI: N/A       | Long             | LON              | CORP              | US        | 1998400   | PA      | $1978985.01   | 0.39%             | 2027-10-12      | Floating      | 9.56%                 | No            | 3                  | On Loan: No      |
| N/A    | Wind Point Partners VIII-A, L.P.                         | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $10604622.00  | 2.07%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | Hellman & Friedman Capital Partners VIII, L.P.           | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $11896513.45  | 2.32%             |  |  |  | No            | N/A                | On Loan: No      |
| N/A    | Charger Investment Partners, L.P.                        | CUSIP: N/A<br>LEI: N/A       | Long             |  | PF                | US        |  | OU      | $4637483.00   | 0.90%             |  |  |  | No            | 3                  | On Loan: No      |

### Signature

**Date Signed:** 2023-01-30

**Name of Applicant:** MVP Private Markets Fund

**Signature:** Dan Iamiceli

**Name of Signer:** Dan Iamiceli

**Title:** Treasurer